Antacid-induced phosphate depletion syndrome presenting as nephrolithiasis. 1990

D L Harmelin, and F I Martin, and J D Wark
Royal Melbourne Hospital, Vic., Australia.

A 29-year-old insulin-dependent diabetic woman developed phosphate depletion, nephrolithiasis and bilateral ureteric obstruction due to antacid abuse. Unlike previous descriptions of chronic phosphate depletion, myalgia, weakness and bone pain were absent. Biochemical features included hypophosphataemia, hypercalciuria, hypophosphaturia, elevated plasma, 1,25-dihydroxyvitamin D and low plasma intact parathyroid hormone. These abnormalities were corrected when antacid ingestion was reduced and phosphate intake supplemented. We propose that phosphate depletion secondary to antacid abuse caused 1 alpha-hydroxylase activation and elevation of the plasma 1,25-dihydroxyvitamin D level, leading to marked hypercalciuria. Once diagnosed, antacid abuse is a readily reversible cause of hypercalciuria and renal stones. Moreover, antacid-induced phosphate depletion may present with nephrolithiasis in the absence of musculoskeletal symptoms. This report is intended to draw attention to this important cause of renal stone disease.

UI MeSH Term Description Entries
D007669 Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE. Kidney Stones,Renal Calculi,Nephrolith,Renal Calculus,Calculi, Kidney,Calculi, Renal,Calculus, Kidney,Calculus, Renal,Kidney Calculus,Kidney Stone,Stone, Kidney,Stones, Kidney
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000863 Antacids Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. Alkalinizing Agent,Antacid,Alkalinizing Agents,Agent, Alkalinizing,Agents, Alkalinizing
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

D L Harmelin, and F I Martin, and J D Wark
February 1974, The Western journal of medicine,
D L Harmelin, and F I Martin, and J D Wark
June 1978, Archives of internal medicine,
D L Harmelin, and F I Martin, and J D Wark
August 1970, Minnesota medicine,
D L Harmelin, and F I Martin, and J D Wark
December 1998, Archives of pediatrics & adolescent medicine,
D L Harmelin, and F I Martin, and J D Wark
February 1995, Clinical pediatrics,
D L Harmelin, and F I Martin, and J D Wark
January 1978, Contributions to nephrology,
D L Harmelin, and F I Martin, and J D Wark
August 1985, Gastroenterology,
D L Harmelin, and F I Martin, and J D Wark
May 1995, Thorax,
D L Harmelin, and F I Martin, and J D Wark
January 2016, Case reports in nephrology,
D L Harmelin, and F I Martin, and J D Wark
January 1978, Advances in experimental medicine and biology,
Copied contents to your clipboard!